Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? | Nasdaq
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva Pharmaceutical: What To Expect In 2023 With New CEO (NYSE:TEVA) | Seeking Alpha
Analyst Ratings for Teva Pharmaceutical Indus | Markets Insider
DEF 14A
Teva Pharmaceutical Stock: Gem Among Generic Pharma Companies (NYSE:TEVA) | Seeking Alpha
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Sell Teva Pharmaceutical due to increasing generic drugs competition: Credit Suisse
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva is primed for a big bounce after years of underperformance, Barclays says
DEF 14A
DEF 14A
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | MarketScreener
Teva plans massive layoffs; Overland Park office's future unclear - Kansas City Business Journal
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Why Teva Pharmaceutical Is Substantially More (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical Rallies, So Let's Adjust Our Bullish Strategy - RealMoney
Teva jumps after Wall Street upgrades, analysts say stock 'too cheap to ignore'
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week (NYSE: TEVA) | Seeking Alpha
Here's Why Teva Shares are Trending Higher Today - TipRanks.com
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
FDA swats back Teva, MedinCell's long-acting schizophrenia drug application | Fierce Pharma
